Dupilumab reduces absenteeism in patients with moderate to severe atopic dermatitis: Pooled results from the LIBERTY AD SOLO clinical trials

de Bruin-Weller, M., Simpson, E.L., Cork, M. orcid.org/0000-0003-4428-2428 et al. (6 more authors) (2020) Dupilumab reduces absenteeism in patients with moderate to severe atopic dermatitis: Pooled results from the LIBERTY AD SOLO clinical trials. Journal of the American Academy of Dermatology, 83 (5). pp. 1499-1501. ISSN 0190-9622

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2020 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Dates:
  • Published (online): 3 June 2020
  • Published: November 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 07 Oct 2020 11:24
Last Modified: 24 May 2022 11:00
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.jaad.2020.05.142
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)